
51 - 200 funcionários
Fundada em 2020
🧬 Biotecnologia
💊 Farmacêutico
🏥 Saúde
💰 $111.828.793 Series A - Syncromune em 2024-12
Biotechnology • Pharmaceuticals • Healthcare
A Syncromune é uma empresa em estágio clínico desenvolvendo uma plataforma inovadora de imunoterapia contra o câncer intratumoral chamada SYNC-T. A plataforma é projetada para ser administrada diretamente nos tumores-alvo para sincronizar o sistema imunológico a fim de reconhecer e destruir o câncer por todo o corpo. Sua terapia investigacional principal, SV-102, está sendo avaliada no estudo LEGION-100 de Fase 2 para câncer de próstata resistente à castração metastático. Os materiais da empresa são direcionados a profissionais de saúde e destacam que seus compostos são investigacionais e ainda não foram aprovados pelas autoridades regulatórias.
🕒 Julho 27
🗣️🇺🇸🇬🇧 Inglês obrigatório
🗣️🇨🇳 Chinês obrigatório
Melhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.

51 - 200 funcionários
Fundada em 2020
🧬 Biotecnologia
💊 Farmacêutico
🏥 Saúde
💰 $111.828.793 Series A - Syncromune em 2024-12
Biotechnology • Pharmaceuticals • Healthcare
A Syncromune é uma empresa em estágio clínico desenvolvendo uma plataforma inovadora de imunoterapia contra o câncer intratumoral chamada SYNC-T. A plataforma é projetada para ser administrada diretamente nos tumores-alvo para sincronizar o sistema imunológico a fim de reconhecer e destruir o câncer por todo o corpo. Sua terapia investigacional principal, SV-102, está sendo avaliada no estudo LEGION-100 de Fase 2 para câncer de próstata resistente à castração metastático. Os materiais da empresa são direcionados a profissionais de saúde e destacam que seus compostos são investigacionais e ainda não foram aprovados pelas autoridades regulatórias.
• Oversee the execution of the analytical strategy for drug substance and drug product development across all phases of clinical development and commercialization. • Oversee method development, validation, transfer, and lifecycle management to ensure compliance with regulatory requirements and alignment with company objectives. • Define and implement analytical development strategies to support CMC programs from early development through commercialization. • Provide technical leadership in analytical sciences, including chromatography, spectroscopy, and characterization techniques. • Guide analytical development activities at CDMO and CTL, including method development, optimization, transfer, validation, troubleshooting, and lifecycle management for GMP test methods for DS and DP. • Guide extended characterizations in support of comparability and regulatory applications. • Foster collaboration with cross-functional groups including Process Development, Quality, and Regulatory Affairs. • Author and review analytical sections of regulatory submissions (IND, IMPD, NDA, BLA). • Ensure adherence to GMP, ICH, and FDA guidelines for analytical activities. • Drive continuous improvement and innovation in analytical technologies and processes. • Supervise CDMO, CTL, and external resources (such as consultants).
• Ph.D. or M.S. degree in Analytical Chemistry, Pharmaceutical Sciences, Biochemistry, or a related field. • 5+ years of pharmaceutical or biotechnology industry experience specializing in analytical development. • Working knowledge of cGMP, ICH, and regulatory guidelines. • Hands-on experience managing global CTLs and CDMOs. • Strong technical expertise in separation science, such as liquid chromatography or mass spectrometry. • Strong technical experience in at least one of the modalities: monoclonal antibody and/or oligonucleotide. • Experience in method development, validation, and lifecycle management for QC methods. • Good to have experience in complex drug products, such as co-formulation, multi-components, conjugates, etc. • Good to have experience in extended characterization & comparability studies to support BLA submission. • Good to have experience in authoring technical and scientific documents for regulatory submissions, including IND and BLA filings. • Good to have late phase experience, such as PPQ and commercialization. • Candidates proficient in both English and Mandarin are highly encouraged to apply. • Ability to work in a fast-paced virtual environment. • Flexibility to travel domestically and internationally as required.
• cash incentive compensation • equity incentive compensation • employee benefits under the Company’s benefit plans
Candidatar-se🕒 Julho 27
Senior Director for technology operations at LOVB, enhancing fan engagement and team performance through technology. Overseeing technology ecosystem and fostering relationships with Pro Team Operators.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 27
Senior Director managing rebate operations and financial performance at WellDyne. Leading a team to maximize rebate value and ensure regulatory compliance.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 27
Associate Director overseeing client experience across HLS portfolio for Coastal Cloud. Leading project teams to drive digital transformation and improve healthcare outcomes.
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 26
Associate Director responsible for care management and utilization management in Health Services Nursing at Humana. Collaborating across teams to optimize performance and improve member outcomes.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $104.000 - $143.000 / ano
⏰ Tempo Integral
🟠 Sênior
👔 Diretor
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 25
Director/Senior Director responsible for national account management and stakeholder negotiations within healthcare. Leading commercial strategy for product launches and market access in biotechnology.
🇺🇸 Estados Unidos – Remoto (EUA)
💰 $10.473.043 Venture Round - Cristcot em 2025-06
⏰ Tempo Integral
🟠 Sênior
👔 Diretor
🗣️🇺🇸🇬🇧 Inglês obrigatório